Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis

Kaulen LD, Karschnia P, Doubrovinskaia S, Abramson JS, Martinez-Lage M, Shankar G, Choi BD, Barnes JA, El-Jawahri A, Hochberg EP, Johnson PC, Soumerai JD, Wick W, Maus MV, Chen YB, Frigault MJ, Dietrich J (2024)

Publication Type: Journal article

Publication year: 2024

Journal

American Journal of Hematology Wiley-Blackwell

DOI: 10.1002/ajh.27505

Involved external institutions

Harvard University US United States (USA) (US) Universitätsklinikum Heidelberg DE Germany (DE)

How to cite

APA:

Kaulen, L.D., Karschnia, P., Doubrovinskaia, S., Abramson, J.S., Martinez-Lage, M., Shankar, G.,... Dietrich, J. (2024). Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis. American Journal of Hematology. https://doi.org/10.1002/ajh.27505

MLA:

Kaulen, Leon D., et al. "Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis." American Journal of Hematology (2024).

BibTeX: Download